Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKCA | P17252 | 4/20 | 0.90 |
| ▸ | PRKCE | Q02156 | 2/20 | 0.90 |
| ▸ | PRKCQ | Q04759 | 2/20 | 0.90 |
| ▸ | PRKCD | Q05655 | 2/20 | 0.90 |
| ▸ | FAAH | O00519 | 3/20 | 0.78 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.78 |
| ▸ | MAPT | P10636 | 1/20 | 0.78 |
| ▸ | HPGD | P15428 | 1/20 | 0.78 |
| ▸ | CNR1 | P21554 | 1/20 | 0.78 |
| ▸ | CNR2 | P34972 | 1/20 | 0.78 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.73 |
| ▸ | SELP | P16109 | 1/20 | 0.69 |
| ▸ | DGKA | P23743 | 1/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29670586 | 1.00 | PRKCA (0.90) | PRKCAPRKCEPRKCQPRKCDFAAH | |
| SCHEMBL8385580 | 1.00 | PRKCA (0.90) | PRKCAPRKCEPRKCQPRKCDFAAH | |
| SCHEMBL29670796 | 1.00 | PRKCA (0.90) | PRKCAPRKCEPRKCQPRKCDFAAH | |
| SCHEMBL31228870 | 1.00 | PRKCA (0.90) | PRKCAPRKCEPRKCQPRKCDFAAH | |
| SCHEMBL1890019 | 1.00 | PRKCA (0.90) | PRKCAPRKCEPRKCQPRKCDFAAH | |
| SCHEMBL30274259 | 1.00 | PRKCA (0.90) | PRKCAPRKCEPRKCQPRKCDFAAH | |
| SCHEMBL29361757 | 1.00 | PRKCA (0.90) | PRKCAPRKCEPRKCQPRKCDFAAH | |
| SCHEMBL6269494 | 1.00 | PRKCA (0.90) | PRKCAPRKCEPRKCQPRKCDFAAH | |
| SCHEMBL21625281 | 1.00 | PRKCA (0.90) | PRKCAPRKCEPRKCQPRKCDFAAH | |
| SCHEMBL29575895 | 1.00 | PRKCA (0.90) | PRKCAPRKCEPRKCQPRKCDFAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 143 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12599572-B2 | Solid lipid nanoparticles of curcumin | Punjab University Chandigarh (IN) | 2026-04-14 | — | — | US | claimed |
| US-20250092360-A1 | METHODS AND COMPOSITIONS FOR GENERATING SOMATOSTATIN+ INTERNEURONS FROM HUMAN FOREBRAIN NEURAL PROGENITOR CELLS | TRAILHEAD BIOSYSTEMS INC. | 2025-03-20 | — | — | US | claimed |
| CN-116559274-A | Biomarker for discriminating benign biliary tract diseases and biliary tract cancers and application thereof | 杭州汇健科技有限公司 | 2023-08-08 | — | — | CN | claimed |
| US-20220151945-A1 | SOLID LIPID NANOPARTICLES OF CURCUMIN | REGISTRAR, PANJAB UNIVERSITY CHANDIGARH (IN) | 2022-05-19 | — | — | US | claimed |
| US-9907758-B2 | Process for preparing solid lipid sustained release nanoparticles for delivery of vitamins | PANJAB UNIVERSITY DEPARTMENT OF BIOTECHNOLOGY (DBT) (IN) | 2018-03-06 | — | — | US | claimed |
| EP-2322934-B1 | A Kit for diagnosing the Alzheimer's disease | BRNI NEUROSCIENCES INST (US) | 2016-08-31 | — | — | EP | claimed |
| US-20140348938-A1 | PROCESS FOR PREPARING SOLID LIPID SUSTAINED RELEASE NANOPARTICLES FOR DELIVERY OF VITAMINS | DEPARTMENT OF BIOTECHNOLOGY (DBT) (IN) | 2014-11-27 | — | — | US | claimed |
| US-20140212949-A1 | METHOD FOR PREPARING MICROVESICULAR ADAM15 | INDUSTRY ACADEMIC COOPERATION FOUNDATION YONSEI UNIVERSITY (KR) | 2014-07-31 | — | — | US | claimed |
| WO-2013105026-A1 | A PROCESS FOR PREPARING SOLID LIPID SUSTAINED RELEASE NANOPARTICLES FOR DELIVERY OF VITAMINS | DEPARTMENT OF BIOTECHNOLOGY (DBT) (IN) | 2013-07-18 | — | — | WO | claimed |
| US-20120238019-A1 | STEM CELL CULTURE MEDIA FOR MAINTAINING STEMNESS OR INDUCING DIFFERENTIATION OF STEM CELLS | COLLEGE OF MEDICINE POCHON CHA UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION (KR) | 2012-09-20 | — | — | US | claimed |
| US-5358714-A | Diacylglycerols as chemical activators of protein kinase C enzymes for inducing and increasing hair growth | UNILEVER PATENT HOLDINGS B.V. (NL) | 1994-10-25 | — | — | US | claimed |
| EP-0334585-B1 | Cosmetic composition | UNILEVER PLC (GB) | 1994-09-14 | — | — | EP | claimed |
| EP-0334585-A2 | Cosmetic composition | UNILEVER PLC (GB) | 1989-09-27 | — | — | EP | claimed |
| US-12599572-B2 | Solid lipid nanoparticles of curcumin | Punjab University Chandigarh (IN) | 2026-04-14 | — | — | US | disclosed |
| US-20260085322-A1 | THERAPEUTIC AGENTS FOR METABOLISM-ASSOCIATED DISEASES | RES & INNOVATION UK (GB) | 2026-03-26 | — | — | US | disclosed |
| US-20250367471-A1 | PERFUSION MODULATED TUMOR DOSE SCULPTING WITH SINGLE DOSE RADIOTHERAPY | MEMORIAL SLOAN KETTERING CANCER CENTER (US) | 2025-12-04 | — | — | US | disclosed |
| EP-0335554-A2 | Cosmetic composition | UNILEVER PLC (GB) | 1989-10-04 | — | — | EP | disclosed |
| EP-0334586-A1 | Carbohydrate lactam derivatives and their use in cosmetic compositions | UNILEVER PLC (GB) | 1989-09-27 | — | — | EP | disclosed |
| EP-0334585-A2 | Cosmetic composition | UNILEVER PLC (GB) | 1989-09-27 | — | — | EP | disclosed |
| EP-0295092-A2 | Skin treatment composition | UNILEVER PLC (GB) | 1988-12-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220151945-A1 | SOLID LIPID NANOPARTICLES OF CURCUMIN | PLIN1, LIPC, NPC1L1 | PRKCA 1368/4885PRKCE 1601/4885PRKCQ 2442/4885 |
| US-20140348938-A1 | PROCESS FOR PREPARING SOLID LIPID SUSTAINED RELEASE NANOPARTICLES FOR DELIVERY OF VITAMINS | VDR, RARA, STRA6 | PRKCA 1047/4885PRKCE 1233/4885PRKCQ 2405/4885 |
| US-20260085322-A1 | THERAPEUTIC AGENTS FOR METABOLISM-ASSOCIATED DISEASES | SCARB1, FABP1, SREBF1 | PRKCA 2453/4885PRKCE 3152/4885PRKCQ 2688/4885 |
| US-12599572-B2 | Solid lipid nanoparticles of curcumin | CPT1A, CPT2, SCD | PRKCA 742/4885PRKCE 552/4885PRKCQ 2571/4885 |
| US-20250367471-A1 | PERFUSION MODULATED TUMOR DOSE SCULPTING WITH SINGLE DOSE RADIOTHERAPY | TP53, CTPS1, TSG101 | PRKCA 2989/4885PRKCE 3582/4885PRKCQ 2495/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.